Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation

Cells. 2021 Apr 13;10(4):881. doi: 10.3390/cells10040881.

Abstract

Rheumatoid arthritis is a chronic, systemic inflammatory disease that carries an increased risk of mortality due to cardiovascular disease. The link between inflammation and atherosclerotic disease is clear; however, recent evidence suggests that inflammation may also play a role in the development of nonischemic heart disease in rheumatoid arthritis (RA) patients. We consider here the link between inflammation and cardiovascular disease in the RA community with a focus on heart failure with preserved ejection fraction. The effect of current anti-inflammatory therapeutics, used to treat RA patients, on cardiovascular disease are discussed as well as whether targeting resolution of inflammation might offer an alternative strategy for tempering inflammation and subsequent inflammation-driven comorbidities in RA.

Keywords: heart failure; inflammation; resolution; rheumatoid arthritis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / genetics
  • Arthritis, Rheumatoid / immunology
  • Atherosclerosis / drug therapy
  • Atherosclerosis / etiology*
  • Atherosclerosis / genetics
  • Atherosclerosis / immunology
  • Etanercept / therapeutic use
  • Heart Failure / drug therapy
  • Heart Failure / etiology*
  • Heart Failure / genetics
  • Heart Failure / immunology
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Inflammation
  • Methotrexate / therapeutic use
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / etiology*
  • Myocardial Infarction / genetics
  • Myocardial Infarction / immunology
  • Myocardial Ischemia / drug therapy
  • Myocardial Ischemia / etiology*
  • Myocardial Ischemia / genetics
  • Myocardial Ischemia / immunology
  • Risk Factors
  • Stroke Volume / drug effects
  • Stroke Volume / physiology
  • Sulfasalazine / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Sulfasalazine
  • Hydroxychloroquine
  • tocilizumab
  • Etanercept
  • Methotrexate